Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.

Autor: Tabaksblat EM; a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark., Langer SW; b Department of Oncology , Rigshospitalet, Faculty of Health Sciences, University of Copenhagen , Copenhagen , Denmark., Knigge U; c Departments of Surgery C and Endocrinology PE , Rigshospitalet, Faculty of Health Sciences, University of Copenhagen , Copenhagen , Denmark., Grønbæk H; d Department of Hepatology and Gastroenterology , Aarhus University Hospital , Aarhus , Denmark., Mortensen J; e Department of Clinical Physiology , Nuclear Medicine & PET, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen , Copenhagen , Denmark., Petersen RH; f Department of Cardiothoracic Surgery , Rigshospitalet, Faculty of Health Sciences, University of Copenhagen , Copenhagen , Denmark., Federspiel BH; g Department of Pathology , Rigshospitalet, Faculty of Health Sciences, University of Copenhagen , Copenhagen , Denmark., Ladekarl M; a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.
Jazyk: angličtina
Zdroj: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2016; Vol. 55 (1), pp. 3-14. Date of Electronic Publication: 2015 Jul 30.
DOI: 10.3109/0284186X.2015.1067715
Abstrakt: Bronchopulmonary neuroendocrine tumours (BP-NET) are a heterogeneous population of neoplasms with different pathology, clinical behaviour and prognosis compared to the more common lung cancers. The management of BP-NET patients is largely based on studies with a low level of evidence and extrapolation of data obtained from more common types of neuroendocrine tumours. This review reflects our view of the current state of the art of diagnosis and treatment of patients with BP-NET.
Databáze: MEDLINE